N. Leigh Anderson

Proteomic analysis of rat soleus muscle undergoing hindlimb suspension-induced atrophy and reweighting hypertrophy.

The human plasma proteome: history, character, and diagnostic prospects.

Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome.

Therapeutic potential of the plasma proteome.

The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins.

Global screening for human viral pathogens.

The human plasma proteome: a nonredundant list developed by combination of four separate sources.

National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report.

An effective and rapid method for functional characterization of immunoadsorbents using POROS beads and flow cytometry.

Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).

The roles of multiple proteomic platforms in a pipeline for new diagnostics.

Proteomics: from basic research to diagnostic application. A review of requirements & needs.

A reagent resource to identify proteins and peptides of interest for the cancer community: a workshop report.

High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance.

Anti-peptide antibody screening: selection of high affinity monoclonal reagents by a refined surface plasmon resonance technique.

A human proteome detection and quantitation project.

SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device.

Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma.

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Candidate List of yoUr Biomarker (CLUB): A Web-based Platform to Aid Cancer Biomarker Research.

A list of candidate cancer biomarkers for targeted proteomics.

The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum.

Introduction: Advances in protein analysis for the clinical laboratory.

Sweetening the pot: adding glycosylation to the biomarker discovery equation.

Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration.

Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.

Mass-spectrometry-based clinical proteomics--a review and prospective.

Libraries of specific assays covering whole proteomes: from yeast to man.

Counting the proteins in plasma.

MALDI immunoscreening (MiSCREEN): a method for selection of anti-peptide monoclonal antibodies for use in immunoproteomics.

Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable results.

Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.

The journey to regulation of protein-based multiplex quantitative assays.

Painting a moving picture: large-scale proteomics efforts and their potential for changing patient care.

Inter-laboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.

Precision of Heavy-Light Peptide Ratios Measured by MALDI-TOF Mass Spectrometry.